Genetics of osteoporosis

Molecular Genetics and Metabolism

Volumn 88, Issue 4, 2006, Pages 295-306

  Huang, Qing Yang ^a,b   Kung, Annie Wai Chee ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b CENTRAL CHINA NORMAL UNIVERSITY   (China)

Author keywords

Association; Bone mineral density; Genetics; Linkage; Osteoporosis

Indexed keywords

BONE DENSITY; BONE MASS; BONE TURNOVER; DNA POLYMORPHISM; FRACTURE; FUNCTIONAL GENOMICS; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENE MAPPING; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC REGULATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOME ANALYSIS; HEREDITY; HUMAN; MARKER GENE; MONOGENIC DISORDER; NONHUMAN; OSTEOPOROSIS; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; RACE DIFFERENCE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEQUENCE HOMOLOGY;

ANIMALS; BONE DENSITY; GENOMICS; HUMANS; LINKAGE (GENETICS); META-ANALYSIS; OSTEOPOROSIS; PHENOTYPE;

ANIMALIA;

EID: 33746277560     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2006.04.009     Document Type: Review

References (116)

1. Melton III L.J. How many women have osteoporosis now?. J. Bone Miner. Res. 10 (1995) 175-177
2. Kanis J.A., Johansson H., Oden A., Johnell O., De Laet C., Eisman J.A., McCloskey E.V., Mellstrom D., Melton III L.J., Pols H.A., Reeve J., Silman A.J., and Tenenhouse A. A family history of fracture and fracture risk: a meta-analysis. Bone 35 (2004) 1029-1037
3. Keen R.W., Hart D.J., Arden N.K., Doyle D.V., and Spector T.D. Family history of appendicular fracture and risk of osteoporosis: a population-based study. Osteoporos. Int. 10 (1999) 161-166
4. Kannus P., Palvanen M., Kaprio J., Parkkari J., and Koskenvuo M. Genetic factors and osteoporotic fractures in elderly people: prospective 25 year follow up of a nationwide cohort of elderly Fannish twins. BMJ 319 (1999) 1334-1337
5. Deng H.W., Chen W.M., Recker S., Stegman M.R., Li J.L., Davies K.M., Zhou Y., Deng H., Heaney R., and Recker R.R. Genetic determination of Colles' fractures and differential bone mass in women with and without Colles' fractures. J. Bone Miner. Res. 15 (2000) 1243-1252
6. Andrew T., Antioniades L., Scurrah K.J., MacGregor A.J., and Spector T.D. The risk of wrist fracture in women is heritable and is influenced by genes that are largely independent of those influencing bone mineral density. J. Bone Miner. Res. 20 (2005) 67-74
7. Deng H.W., Mahaney M.G., Williams J.T., Li J., Conway T., Davies K.M., Li J.L., Deng H., and Recker R.R. Relevance of the genes for bone mass variation to susceptibility to osteoporotic fractures and its implications to gene search for complex human diseases. Gene Epidemiol. 22 (2002) 12-25
8. Ioannidis J.P., Ralston S.H., Bennett S.T., Brandi M.L., Grinberg D., Karassa F.B., Langdahl B., van Meurs J.B., Mosekilde L., Scollen S., Albagha O.M., Bustamante M., Carey A.H., Dunning A.M., Enjuanes A., van Leeuwen J.P., Mavilia C., Masi L., McGuigan F.E., Nogues X., Pols H.A., Reid D.M., Schuit S.C., Sherlock R.E., and Uitterlinden A.G. GENOMOS Study. Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes. JAMA 292 (2004) 2105-2114
9. Fang Y., van Meurs J.B.J., d'Alesio A., Jhamai M., Zhao H., Rivadeneira F., Hofman A., van Leeuwen J.P.T., Jehan F., Pols H.A.P., and Uitterlinden A.G. Promoter and 3′-untranslated-region haplotypes in the vitamin D receptor gene predispose to osteoporotic fractures: the Rotterdam study. Am. J. Hum. Genet. 77 (2005) 807-823
10. Peacock M., Turner C.H., Econs M.J., and Foroud T. Genetics of osteoporosis. Endocr. Rev. 23 (2002) 303-326
11. Karasik D., Cupples L.A., Hannan M.T., and Kiel D.P. Genome screen for a combined bone phenotype using principal component analysis: the Framingham study. Bone 34 (2004) 547-556
12. Brown M.A. Genetic studies of osteoporosis-a rethink required. Calcif. Tissue Int. 76 (2005) 319-325
13. Mouse Genome Sequencing Consortium, Initial sequencing and comparative analysis of the mouse genome, Nature 420 (2002) 520-562.
14. Huang Q.Y., Recker R.R., and Deng H.W. Searching for osteoporosis genes in the post-genome era: progress and challenges. Osteoporos. Int. 14 (2003) 701-715
15. Klein R.F., Allard J., Avnur Z., Nikolcheva T., Rotstein D., Carlos A.S., Shea M., Waters R.V., Belknap J.K., Peltz G., and Orwoll E.S. Regulation of bone mass in mice by the lipoxygenase gene Alox15. Science 303 (2004) 229-232
16. Urano T., Shiraki M., Fujita M., Hosoi T., Orimo H., Ouchi Y., and Inoue S. Association of a single nucleotide polymorphism in the lipoxygenase ALOX15 5′-flanking region (-229G/A) with bone mineral density. J. Bone Miner. Metab. 23 (2005) 226-230
17. Ichikawa S., Koller D.L., Johnson M.L., Lai D., Xuei X., Edenberg H.J., Klein R.F., Orwoll E.S., Hui S.L., Foroud T.M., Peacock M., and Econs M.J. Human ALOX12, but not ALOX15, is associated with bone mineral density in white men and women. J. Bone Miner. Res. 21 (2006) 556-564
18. Benes H., Weinstein R.S., Zheng W., Thaden J.J., Jilka R.L., Manolagas S.C., and Reis R.J. Chromosomal mapping of osteopenia-associated quantitative trait loci using closely related mouse strains. J. Bone Miner. Res. 15 (2000) 626-633
19. Parsons C.A., Mroczkowski H.J., McGuigan F.E., Albagha O.M., Manolagas S., Reid D.M., Ralston S.H., and Reis R.J. Interspecies synteny mapping identifies a quantitative trait locus for bone mineral density on human chromosome Xp22. Hum. Mol. Genet. 14 (2005) 3141-3148
20. Orwoll E.S., Belknap J.K., and Klein R.F. Gender specificity in the genetic determinants of peak bone mass. J. Bone Miner. Res. 16 (2001) 1962-1971
21. Peacock M., Koller D.L., Fishburn T., Krishnan S., Lai D., Hui S.L., Johnston C.C., Foroud T., and Econs M.J. Sex-specific and non-sex-specific quantitative trait loci contribute to normal variation in bone mineral density in men. J. Clin. Endocrinol. Metab. 90 (2005) 3060-3066
22. Ralston S.H., Galwey N., MacKay I., Albagha O.M.E., Cardon L., Compston J.E., Cooper C., Duncan E., Keen R., Langdahl B., McLellan A., O'Riordan J., Pols H.A., Reid D.M., Uitterlinden A.G., Wass J., and Bennett S.T. Loci for regulation of bone mineral density in men and women identified by genome wide linkage scan: the FAMOS study. Hum. Mol. Genet. 14 (2005) 943-951
23. Ralston S.H. Genetic control of susceptibility to osteoporosis. J. Clin. Endocrinol. Metab. 87 (2002) 2460-2466
24. Mann V., Hobson E.E., Li B., Stewart T.L., Grant S.F., Robins S.P., Aspden R.M., and Ralston S.H. A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality. J. Clin. Invest. 107 (2001) 899-907
25. Efstathiadou Z., Tsataoulis A., and Ioannidis J.P.A. Association of collagen Iα 1 Sp1 polymorphism with the risk of prevalent fractures: a meta-analysis. J. Bone Miner. Res. 16 (2001) 1586-1592
26. Ralston S.H., Uitterlinden A.G., Brandi M.L., Balcells S., Langdahl B.L., Lips P., Lorenc R., Obermayer-Pietsch B., Scollen S., Bustamante M., Husted L.B., Carey A.H., Diez-Perez A., Dunning A.M., Falchetti A., Karczmarewicz E., Kruk M., Leeuwen J.P., Meurs J.B., Mangion J., McGuigan F.E., Mellibovsky L., Monte F.D., Pols H.A., Reeve J., Reid D.M., Renner W., Rivadeneira F., Schoor N.M., Sherlock R.E., and Ioannidis J.P. Large-scale evidence for the effect of the COLIA1 Sp1 polymorphism on osteoporosis outcomes: the GENOMOS study. PLoS Med. 3 (2006) e90
27. Gong Y., Slee R.B., Fukai N., Rawadi G., Roman-Roman S., Reginato A.M., Wang H., Cundy T., Glorieux F.H., Lev D., Zacharin M., Oexle K., Marcelino J., Suwairi W., Heeger S., Sabatakos G., Apte S., Adkins W.N., Allgrove J., Arslan-Kirchner M., Batch J.A., Beighton P., Black G.C., Boles R.G., Boon L.M., Borrone C., Brunner H.G., Carle G.F., Dallapiccola B., De Paepe A., Floege B., Halfhide M.L., Hall B., Hennekam R.C., Hirose T., Jans A., Juppner H., Kim C.A., Keppler-Noreuil K., Kohlschuetter A., LaCombe D., Lambert M., Lemyre E., Letteboer T., Peltonen L., Ramesar R.S., Romanengo M., Somer H., Steichen-Gersdorf E., Steinmann B., Sullivan B., Superti-Furga A., Swoboda W., van den Boogaard M.J., Van Hul W., Vikkula M., Votruba M., Zabel B., Garcia T., Baron R., Olsen B.R., Warman M.L., and Osteoporosis-Pseudoglioma Syndrome Collaborative Group. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107 (2001) 513-523
28. Little R.D., Carulli J.P., Del Mastro R.J., Dupuis J., Osborne M., Folz C., Manning S.P., Swain P.M., Zhao S.C., Eustace B., Lappe M.M., Spitzer L., Zweier S., Braunschweiger K., Benchekroun Y., Hu X., Adair R., Chee L., FitzGerald M.G., Tulig C., Caruso A., Tzellas N., Bawa A., Franklin B., McGuire S., Nogues X., Gong G., Allen K.M., Anisowicz A., Morales A.J., Lomedico P.T., Recker S.M., Van Eerdewegh P., Recker R.R., and Johnson M.L. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am. J. Hum. Genet. 70 (2002) 11-19
29. Boyden L.M., Mao J., Belsky J., Mitzner L., Farhi A., Mitnick M.A., Wu D., Insogna K., and Lifton R.P. High bone density due to a mutation in LDL-receptor-related protein 5. N. Engl. J. Med. 346 (2002) 1513-1521
30. Koay M.A., Woon P.Y., Zhang Y., Miles L.J., Duncan E.L., Ralston S.H., Compston J.E., Cooper C., Keen R., Langdahl B.L., MacLelland A., O'Riordan J., Pols H.A., Reid D.M., Uitterlinden A.G., Wass J.A., and Brown M.A. Influence of LRP5 polymorphisms on normal variation in BMD. J. Bone Miner. Res. 19 (2004) 1619-1627
31. Urano T., Shiraki M., Ezura Y., Fujita M., Sekine E., Hoshino S., Hosoi T., Orimo H., Emi M., Ouchi Y., and Inoue S. Association of a single-nucleotide polymorphism in low-density lipoprotein receptor-related protein 5 gene with bone mineral density. J. Bone Miner. Metab. 22 (2004) 341-345
32. Koh J.M., Jung M.H., Hong J.S., Park H.J., Chang J.S., Shin H.D., Kim S.Y., and Kim G.S. Association between bone mineral density and LDL receptor-related protein 5 gene polymorphisms in young Korean men. J. Korean Med. Sci. 19 (2004) 407-412
33. Mizuguchi T., Furuta I., Watanabe Y., Tsukamoto K., Tomita H., Tsujihata M., Ohta T., Kishino T., Matsumoto N., Minakami H., Niikawa N., and Yoshiura K. LRP5, low-density-lipoprotein-receptor-related protein 5, is a determinant for bone mineral density. J. Hum. Genet. 49 (2004) 80-86
34. Ferrari S.L., Deutsch S., Choudhury U., Chevalley T., Bonjour J.P., Dermitzakis E.T., Rizzoli R., and Antonarakis S.E. Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites. Am. J. Hum. Genet. 74 (2004) 866-875
35. Koller D.L., Ichikawa S., Johnson M.L., Lai D., Xuei X., Edenberg H.J., Conneally P.M., Hui S.L., Johnston C.C., Peacock M., Foroud T., and Econs M.J. Contribution of the LRP5 gene to normal variation in peak BMD in women. J. Bone Miner. Res. 20 (2005) 75-80
36. Zhang Z.L., Qin Y.J., He J.W., Huang Q.R., Li M., Hu Y.Q., and Liu Y.J. Association of polymorphisms in low-density lipoprotein receptor-related protein 5 gene with bone mineral density in postmenopausal Chinese women. Acta Pharmacol. Sin. 26 (2005) 1111-1116
37. Bollerslev J., Wilson S.G., Dick I.M., Islam F.M., Ueland T., Palmer L., Devine A., and Prince R.L. LRP5 gene polymorphisms predict bone mass and incident fractures in elderly Australian women. Bone 36 (2005) 599-606
38. Meurs J.B., Rivadeneira F., Jhamai M., Hugens W., Hofman A., Leeuwen J.P., Pols H.A., and Uitterlinden A.G. Common genetic variation of the low-density lipoprotein receptor-related protein 5 and 6 genes determines fracture risk in elderly white men. J. Bone Miner. Res. 21 (2006) 141-150
39. Frattini A., Orchard P.J., Sobacchi C., Giliani S., Abinun M., Mattsson J.P., Keeling D.J., Andersson A.K., Wallbrandt P., Zecca L., Notarangelo L.D., Vezzoni P., and Villa A. Defects in TCIRGI subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis. Nat. Genet. 25 (2000) 343-346
40. Sobacchi C., Vezzoni P., Reid D.M., McGuigan F.E., Frattini A., Mirolo M., Albhaga O.M., Musio A., Villa A., and Ralston S.H. Association between a polymorphism affecting an AP1 binding site in the promoter of the TCIRG1 gene and bone mass in women. Calcif. Tissue Int. 74 (2004) 35-41
41. Koller D.L., Econs M.J., Morin P.A., Christian J.C., Hui S.L., Parry P., Curran M.E., Rodriguez L.A., Conneally P.M., Joslyn G., Peacock M., Johnston C.C., and Foroud T. Genome scan for QTLs contributing to normal variation in bone mineral density and osteoporosis. J. Clin. Endocrinol. Metab. 85 (2000) 3116-3120
42. Langdahl B.L., Knudsen J.Y., Jensen H.K., Gregersen N., and Eriksen E.F. A sequence variation: 713-8delC in the transforming growth factor-beta 1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and increased bone turnover in both osteoporotic and normal women. Bone 20 (1997) 289-294
43. Yamada Y., Miyauchi A., Takagi Y., Tanaka M., Mizuno M., and Harada A. Association of the C-509->T polymorphism, alone of in combination with the T869->C polymorphism, of the transforming growth factor-beta1 gene with bone mineral density and genetic susceptibility to osteoporosis in Japanese women. J. Mol. Med. 79 (2001) 149-156
44. Lau H.H.L., Ho A.Y.Y., Luk K.D.K., and Kung A.W.C. Transforming growth factor-β1 gene polymorphisms and bone turnover, bone mineral density and fracture risk in southern Chinese women. Calcif. Tissue Int. 74 (2004) 516-521
45. Balemans W., Patel N., Ebeling M., Van Hul E., Wuyts W., Lacza C., Dioszegi M., Dikkers F.G., Hildering P., Willems P.J., Verheij J.B., Lindpaintner K., Vickery B., Foernzler D., and Van Hul W. Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease. J. Med. Genet. 39 (2002) 91-97
46. Brunkow M., Gardner J., Van Ness J., Paeper B.W., Kovacevich B.R., Proll S., Skonier J.E., Zhao L., Sabo P.J., Fu Y., Alisch R.S., Gillett L., Colbert T., Tacconi P., Galas D., Hamersma H., Beighton P., and Mulligan J. Bone dysplasia sclerosteosis results from loss of the sost gene product, a novel cystine knot-containing protein. Am. J. Hum. Genet. 68 (2001) 577-589
47. Balemans W., Ebeling M., Patel N., Van Hul E., Olson P., Dioszegi M., Lacza C., Wuyts W., Van Den Ende J., Willems P., Paes-Alves A.F., Hill S., Bueno M., Ramos F.J., Tacconi P., Dikkers F.G., Stratakis C., Lindpaintner K., Vickery B., Foernzler D., and Van Hul W. Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum. Mol. Genet. 10 (2001) 537-543
48. Uitterlinden A.G., Arp P.P., Paeper B.W., Charmley P., Proll S., Rivadeneira F., Fang Y., van Meurs J.B., Britschgi T.B., Latham J.A., Schatzman R.C., Pols H.A., and Brunkow M.E. Polymorphisms in the Sclerosteosis/van Buchem disease gene (SOST) region are associated with bone-mineral density in elderly whites. Am. J. Hum. Genet. 75 (2004) 1032-1045
49. Pettersson U., Albagha O.M.E., Mirolo M., Taranta A., Frattini A., McGuigan F.E.A., Vezzoni P., Teti A., Hul W.V., Reid D.M., Villa A., and Ralston S.H. Polymorphisms of the CLCN7 gene are associated with BMD in women. J. Bone Miner. Res. 20 (2005) 1960-1967
50. Kornak U., Ostertag A., Branger S., Benichou O., and de Vernejoul M.C. Polymorphisms in the CLCN7 gene modulate bone density in postmenopausal women and in patients with autosomal dominant osteopetrosis type II. J. Clin. Endocrinol. Metab. 91 (2006) 995-1000
51. Liu Y.Z., Liu Y.J., Recker R.R., and Deng H.W. Molecular studies of identification of genes for osteoporosis: the 2002 update. J. Endocrinol. 177 (2003) 147-196
52. Ioannidis J.P., Ntzani E.E., Trikalinos T.A., and Contopoulos-Ioannidis D.G. Replication validity of genetic association studies. Nat. Genet. 29 (2001) 306-309
53. Lohmueller K.E., Pearce C.L., Pike M., Lander E.S., and Hirschhorn J.N. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat. Genet. 33 (2003) 177-182
54. Ioannidis J.P. Genetic associations: false or true. Trend Genet. 9 (2003) 135-138
55. Gong G., Stern H.S., Cheng S.C., Fong N., Mordeson J., Deng H.W., and Recker R.R. The association of bone mineral density with vitamin D receptor gene polymorphisms. Osteoporos. Int. 9 (1999) 55-64
56. Thakkinstian A., D'Este C., Eisman J., Nguyen T., and Attia J. Meta-analysis of molecular association studies: vitamin D receptor gene polymorphisms and BMD as a case study. J. Bone Miner. Res. 19 (2004) 419-428
57. Nejentsev S., Godfrey L., Snook H., Rance H., Nutland S., Walker N.M., Lam A.C., Guja C., Ionescu-Tirgoviste C., Undlien D.E., Ronningen K.S., Tuomilehto-Wolf E., Tuomilehto J., Newport M.J., Clayton D.G., and Todd J.A. Comparative high-resolution analysis of linkage disequilibrium and tag single nucleotide polymorphisms between populations in the vitamin D receptor gene. Hum. Mol. Genet. 13 (2004) 1633-1639
58. Macdonald H.M., McGuigan F.E., Stewart A., Black A.J., Fraser W.D., Ralston S., and Reid D.M. Large-scale population-based study shows no evidence of association between common polymorphism of the VDR gene and BMD in British women. J. Bone Miner. Res. 21 (2006) 151-162
59. A.G. Uitterlinden, S.H. Ralston, M.L. Brandi, A.H. Carey, B.L. Langdahl, P. Lips, R. Lorenc, B. Obermayer-Pietsch, J. Reeve, D.M. Reid, A. Amidei, A. Bassiti, M. Bustamante, L.B. Husted, A. Diez-Perez, H. Dobnig, A. M. Dunning, A. Enjuanes, A. Fahrleitner-Pammer, Y. Fang, E. Karczmarewicz, M. Kruk, J.P. Leeuwen, C. Mavilia, J.B. Meurs, J. Mangion, F.E. McGuigan, H. A. Pols, W. Renner, F. Rivadeneira, N. M. Schoor, S. Scollen, R.E. Sherlock, J.P. Ioannidis, Large-scale analysis of association between common vitamin D receptor gene variations and osteoporosis: the GENOMOS study, Ann. Int. Med., in press.
60. Niu T., and Rosen C.J. The insulin-like growth factor-I gene and osteoporosis: a critical appraisal. Gene 361 (2005) 38-56
61. Y.H. Hsu, et al., Moving between mouse and humans to identify a candidate gene on chromosome 10 that affects serum IGF-I, bone turnover, and bone mineral density, J. Bone Miner. Res., in press.
62. Ioannidis J.P., Stavrou I., Trikalinos T.A., Zois C., Brandi M.L., Gennari L., Albagha O., Ralston S.H., and Tsatsoulis A. Association of polymorphisms of the estrogen receptor α gene with bone mineral density and fracture risk in women: a meta-analysis. J. Bone Miner. Res. 17 (2002) 2048-2060
63. Munafo M.R., and Flint J. Meta-analysis of genetic association studies. Trend Genet. 20 (2004) 439-443
64. Altshuler D., Hirschhorn J.N., Klannemark M., Lindgren C.M., Vohl M.C., Nemesh J., Lane C.R., Schaffner S.F., Bolk S., Brewer C., Tuomi T., Gaudet D., Hudson T.J., Daly M., Groop L., and Lander E.S. The common PPAR gamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat. Genet. 26 (2000) 76-80
65. Lee Y.H., Rho Y.H., Choi S.J., Ji J.D., and Song G.G. Meta-analysis of genome-wide linkage studies for bone mineral density. J. Hum. Genet. 51 (2006) 480-486
66. International HapMap Consortium, A haplotype map of the human genome, Nature 437 (2005) 1299-1320.
67. Devoto M., Shimoya K., Caminis J., Ott J., Tenenhouse A., Whyte M.P., Sereda L., Hall S., Considine E., Williams C.J., Tromp G., Kuivaniemi H., Ala-Kokko L., Prockop D.J., and Spotila L.D. First-stage autosomal genome screen in extended pedigrees suggests genes predisposing to low bone mineral density on chromosomes 1p, 2p and 4q. Eur. J. Hum. Genet. 6 (1998) 151-157
68. Devoto M., Specchia C., Li H.H., Caminis J., Tenenhouse A., Rodriguez H., and Spotila L.D. Variance component linkage analysis indicates a QTL for femoral neck bone mineral density on chromosomes 1p36. Hum. Mol. Genet. 10 (2001) 2447-2452
69. Niu T., Chen C., Cordel H., Yang J., Wang B., Wang Z., Fang Z., Schork N.J., Rosen C.J., and Xu X. A genome-wide scan for loci linked to forearm bone mineral density. Hum. Genet. 104 (1999) 226-233
70. Econs M.J., Koller D.L., Hui S.L., Fishburn T., Conneally P.M., Johnston C.C., Peacock M., and Foroud T. Confirmation of linkage to chromosome 1q for paek vertebral bone mineral density in premenopausal white women. Am. J. Hum. Genet. 74 (2004) 223-228
71. Peacock M., Koller D.L., Hui S.L., Johnston C.C., Foroud T., and Econs M.J. Peak bone mineral density at the hip is linked to chromosomes 14q and 15q. Osteoporos. Int. 15 (2004) 489-496
72. Deng H.W., Xu F.H., Huang Q.Y., Shen H., Deng H.Y., Conway T., Liu Y.J., Liu Y.Z., Li J.L., Zhang H.T., Davies K.M., and Recker R.R. A whole-genome linkage scan suggests several genomic regions potentially containing quantitative trait loci for osteoporosis. J. Clin. Endocrinol. Metab. 87 (2002) 5151-5159
73. Shen H., Zhang Y.Y., Long J.R., Xu F.H., Liu Y.Z., Xiao P., Zhao L.J., Xiong D.H., Liu Y.J., Dvornyk V., Rocha-Sanchez S., Liu P.Y., Li J.L., Conway T., Davies K.M., Recker R.R., and Deng H.W. A genome-wide linkage scan for bone mineral density in an extended sample: evidence for linkage on 11q23 and xq27. J. Med. Genet. 41 (2004) 743-751
74. Karasik D., Myers R.H., Cupples L.A., Hannan M.T., Gagnon D.R., Herbert A., and Kiel D.P. Genome screen for quantitative trait loci contributing to normal variation in bone mineral density: the framingham study. J. Bone Miner. Res. 17 (2002) 1718-1727
75. Kammerer C.M., Schneider J.L., Cole S.A., Hixson J.E., Samollow P.B., O'Connell J.R., Perez R., Dyer T.D., Almasy L., Blangero J., Bauer R.L., and Mitchell B.D. Quantitative trait loci on chromosome 2p, 4p, and 13q influence bone mineral density of the forearm and hip in Mexican American. J. Bone Miner. Res. 18 (2003) 2245-2252
76. Styrkarsdottir U., Cazier J., Kong A., Rolfsson O., Larsen H., Bjarnadottir E., Johannsdottir V.D., Sigurdardottir M.S., Bagger Y., Christiansen C., Reynisdottir I., Grant S.F., Jonasson K., Frigge M.L., Gulcher J.R., Sigurdsson G., and Stefansson K. Linkage of osteoporosis to chromosome 20p12 and association to BMP2. PLoS Biol. 1 (2003) E69
77. Wilson S.G., Reed P.W., Bansal A., Chiano M., Lindersson M., Langdown M., Prince R.L., Thompson D., Thompson E., Bailey M., Kleyn P.W., Sambrook P., Shi M.M., and Spector T.D. Comparison of genome screens for two independent cohorts provides replication of suggestive linkage of bone mineral density to 3p21 and 1p36. Am. J. Hum. Genet. 72 (2003) 144-155
78. Devoto M., Spotila L.D., Stabley D.L., Wharton G.N., Rydbeck H., Korkko J., Kosich R., Prockop D., Tenenhouse A., and Sol-Church K. Univariate and bivariate variance component linkage analysis of a whole-genome scan for loci contributing to bone mineral density. Eur. J. Hum. Genet. 13 (2005) 781-788
79. Duncan E.L., Brown M.A., Sinsheimer J., Bell J., Carr A.J., Wordsworth B.P., and Wass J.A. Suggestive linkage of the parathyroid receptor type 1 to osteoporosis. J. Bone Miner. Res. 14 (1999) 1993-1999
80. Reneland R.H., Mah S., Kammere S., Hoyal C.R., Marnellos G., Wilson S.G., Sambrook P.N., Spector T.D., Nelson M.R., and Braun A. Association between a variation in the phosphodiesterase 4D gene and bone mineral density. BMC Med. Genet. 6 (2005) 9
81. Ichikawa S., Johnson M.L., Koller D.L., Lai D., Xuei X., Edenberg H.J., Hui S.L., Foroud T.M., Peacock M., and Econs M.J. Polymorphisms in the bone morphogenetic protein 2 (BMP2) gene do not affect bone mineral density in white men or women. Osteoporos. Int. 17 (2006) 587-592
82. Medici M., Meurs J.B., Rivadeneira F., Zhao H.Y., Arp P.P., Hofman A., Pols H.A., and Uitterlinden A.G. BMP-2 gene polymorphisms and osteoporosis: the Rotterdam study. J. Bone Miner. Res. 21 (2006) 845-854
83. Carlson C.S., Eberle M.A., Kruglyak L., and Nickerson D.A. Mapping complex disease loci in whole-genome association studies. Nature 429 (2004) 446-452
84. Hirschhorn J.N., and Daly M.J. Genome-wide association studies for common diseases and complex traits. Nat. Rev. Genet. 6 (2005) 95-108
85. Wang W.Y.S., Barratt B.J., Clayton D.G., and Todd J.A. Genomewide association studies: theoretical and practical concerns. Nat. Rev. Genet. 6 (2005) 109-118
86. Thomas D.C., Haile R.W., and Duggan D. Recent developments in genomewide association scans: a workshop summary and review. Am. J. Hum. Genet. 77 (2005) 337-345
87. Klein R.J., Zeiss C., Chew E.Y., Tsai J.Y., Sackler R.S., Haynes C., Henning A.K., SanGiovanni J.P., Mane S.M., Mayne S.T., Bracken M.B., Ferris F.L., Ott J., Barnstable C., and Hoh J. Complement factor H polymorphism in age-related macular degeneration. Science 308 (2005) 385-389
88. Maraganore D.M., de Andrade M., Lesnick T.G., Strain K.J., Farrer M.J., Rocca W.A., Pant P.V.K., Frazer K.A., Cox D.R., and Ballinger D.G. High-resolution whole-genome association study of parkinson disease. Am. J. Hum. Genet. 76 (2005) 672-680
89. Cheung V.G., Spielman R.S., Ewens K.G., Weber T.M., Morley M., and Burdick J.T. Mapping determinants of human gene expression by regional and genome-wide association. Nature 437 (2005) 1365-1369
90. Jais P.H. How frequent is altered gene expression among susceptibility genes to human complex disorders?. Genet. Med. 7 (2005) 83-96
91. Lawn R.M., Wade D.P., Garvin M.R., Wang X., Schwartz K., Porter J.G., Seilhamer J.J., Vaughan A.M., and Oram J.F. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J. Clin. Invest. 104 (1999) R25-R31
92. Mootha V.K., Lepage P., Miller K., Bunkenborg J., Reich M., Hjerrild M., Delmonte T., Villeneuve A., Sladek R., Xu F., Mitchell G.A., Morin C., Mann M., Hudson T.J., Robinson B., Rioux J.D., and Lander E.S. Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics. Proc. Natl. Acad. Sci. USA 100 (2003) 605-610
93. Li J., and Burmeister M. Genetical genomics: combining genetics with gene expression analysis. Hum. Mol. Genet. 14 (2005) R163-R169
94. Gibson G., and Weir B. The quantitative genetics of transcription. Trends Genet. 21 (2005) 616-623
95. Schadt E.E. Exploiting naturally occurring DNA variation and molecular profiling data to dissect disease and drug response traits. Curr. Opin. Biotechnol. 16 (2005) 1-8
96. Schadt E.E., Lamb J., Yang X., Zhu J., Edwards S., Guhathakurta D., Sieberts S.K., Monks S., Reitman M., Zhang C., Lum P.Y., Leonardson A., Thieringer R., Metzger J.M., Yang L., Castle J., Zhu H., Kash S.F., Drake T.A., Sachs A., and Lusis A.J. An integrative genomics approach to infer causal associations between gene expression and disease. Nat. Genet. 37 (2005) 710-717
97. Hubner N., Wallace C.A., Zimdahl H., Petretto E., Schulz H., Maciver F., Mueller M., Hummel O., Monti J., Zidek V., Musilova A., Kren V., Causton H., Game L., Born G., Schmidt S., Muller A., Cook S.A., Kurtz T.W., Whittaker J., Pravenec M., and Aitman T.J. Integrated transcriptional profiling and linkage analysis for identification of genes underlying disease. Nat. Genet. 37 (2005) 243-253
98. Mehrabian M., Allayee H., Stockton J., Lum P.Y., Drake T.A., Castellani L.W., Suh M., Armour C., Edwards S., Lamb J., Lusis A.J., and Schadt E.E. Integrating genotypic and expression data in a segregating mouse population to identify 5-lipoxygenase as a susceptibility gene for obesity and bone traits. Nat. Genet. 37 (2005) 1224-1233
99. Miklos G.L.G., and Maleszka R. Microarray reality checks in the context of a complex disease. Nature Biotechnol. 22 (2004) 615-621
100. Liu Y.Z., Dvornyk V., Lu Y., Shen H., Lappe J.M., Recker R.R., and Deng H.W. A novel pathophysiological mechanism for osteoporosis suggested by an in vivo gene expression study of circulating monocytes. J. Bio. Chem. 280 (2005) 29011-29016
101. Hunter D.J. Gene-environment interactions in human diseases. Nat. Rev. Genet. 6 (2005) 287-298
102. Hoh J., and Ott J. Mathematical multi-locus approaches to localizing complex human trait genes. Nat. Rev. Genet. 4 (2003) 701-709
103. Marchini J., Donnelly P., and Cardon L.R. Genome-wide strategies for detecting multiple loci that influence complex diseases. Nature Genet. 37 (2005) 413-417
104. Cordell H.J. Epistasis: what it means, what is doesn't mean, and statistical methods to detect it in humans. Hum. Mol. Genet. 11 (2002) 2463-2468
105. Willing M., Sowers M., Aron D., Clark M.K., Burns T., Bunten C., Crutchfield M., D'Agostino D., and Jannausch M. Bone mineral density and its change in white women: estrogen and vitamin D receptor genotypes and their interaction. J. Bone Miner. Res. 13 (1998) 695-705
106. Gennari L., Becherini L., Masi L., Mansani R., Gonnelli S., Cepollaro C., Martini S., Montagnani A., Lentini G., Becorpi A.M., and Brandi M.L. Vitamin D and estrogen receptor allelic variants in Italian postmenopausal women: evidence of multiple gene contribution to bone mineral density. J. Clin. Endocrinol. Metab. 83 (1998) 939-944
107. Deng H.W., Li J., Li J.L., Johnson M., Gong G., and Recker R.R. Association of VDR and estrogen receptor genotypes with bone mass in postmenopausal Caucasian women: different conclusions with different analyses and the implications. Osteoporos. Int. 9 (1999) 499-507
108. Zhang Y.Y., Long J.R., Liu P.Y., Liu Y.J., Shen H., Zhao L.J., and Deng H.W. Estrogen receptor alpha and vitamin D receptor gene polymorphisms and bone mineral density: association study of healthy pre- and postmenopausal Chinese women. Biochem. Biophys. Res. Commun. 308 (2003) 777-783
109. Uitterlinden A.G., Weel A.E., Burger H., Fang Y., van Duijn C.M., Hofman A., Leeuwen J.P., and Pols H.A. Interaction between the vitamin D receptor gene and collagen type I alpha1 gene in susceptibility for fracture. J. Bone Miner. Res. 16 (2001) 379-385
110. Colin E.M., Uitterlinden A.G., Meurs J.B.J., Bergink A.P., Van De Klift M., Fang Y., Arp P.P., Hofman A., Leeuwen J.P., and Pols H.A. Interaction between vitamin D receptor genotype and estrogen receptor α genotype influences vertebral fracture risk. J. Clin. Endocrinol. Metab. 88 (2003) 3777-3784
111. Ferrari S.L., Karasik D., Liu J., Karamohamed S., Herbert A.G., Cupples L.A., and Kiel D.P. Interactions of interleukin-6 promoter polymorphisms with dietary and lifestyle factors and their association with bone mass in men and women from the Framingham Osteoporosis Study. J. Bone Miner. Res. 19 (2004) 552-559
112. Dennison E.M., Arden N.K., Keen R.W., Syddall H., Day I.N., Spector T.D., and Cooper C. Birthweight, vitamin D receptor genotype and the programming of osteoporosis. Paediatr. Perinat. Epidemiol. 15 (2001) 211-219
113. Harris M., Nguyen T.V., Howard G.M., Kelly P.J., and Eisman J.A. Genetic and environmental correlations between bone formation and bone mineral density: a twin study. Bone 22 (1998) 141-145
114. Duncan E.L., Cardon L.R., Sinsheimer J.R., Wass J.A., and Brown M.A. Site and gender specificity of inheritance of bone mineral density. J. Bone Miner. Res. 18 (2003) 1531-1538
115. Weiss L.A., Pan L., Abney M., and Ober C. The sex-specific genetic architecture of quantitative traits in humans. Nat. Genet. 38 (2006) 218-222
116. Ioannidis J.P., Ntzani E.E., and Trikalinos T.A. 'Racial' differences in genetic effects for complex diseases. Nat. Genet. 36 (2004) 1312-1318